Skip to content

Gilead Sciences says drug proved effective against virus in U.S. study

Gilead Sciences’ remdesivir would be the first treatment to pass such a test against the virus, which has killed more than 218,000 people since it emerged late last year.

In this March photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material.
In this March photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material.Read moreAP
    by Marilynn Marchione, The Associated Press
    Published